Medical Breakthrough 4 min read
Custom mRNA Vaccines Tailored to Individual Tumors Show Breakthrough Results in Breast Cancer Trial
Phase 1 trial reveals personalized mRNA vaccines designed from each patient's unique tumor mutations trigger powerful, long-lasting immune responses against triple-negative breast cancer. Early results show improved outcomes compared to standard treatments.